Baebies is a biotech startup developing products and services for newborn screening and pediatric testing.
Baebies' mission is to save lives and make lives better for all children by bringing new technologies, new tests and new hope to parents and healthcare professionals worldwide.
Baebies was founded in 2014 by Richard West and Vamsee Pamula. The company is headquartereed in Durham, North Carolina.
Baebies' products are powered by digital microfluidics (DMF), an innovative technology to electronically manipulate microliter-sized drops of liquid. It miniaturize conventional diagnostic testing to enable faster results using smaller sample sizes.
Baebies’ products include SEEKER, a FDA cleared and CE marked newborn screening platform for lysosomal storage disorders, and FINDERTM, a near patient pediatric testing platform that is under development and not available at this time for sale or use in any territory.
Baebies has now licensed its core technology, acquired product and manufacturing assets. The company has delivered over 12 million screenings.
Baebies is backed by BOE Technology Group Co. Ltd., North Carolina Biotechnology Center, and others. The company raised $12M in a Debt financing on Feb 10, 2022. This brings Baebies' total funding to $82.3M to date.